Learn More
Medchemexpress LLC N-[[4-(benzamidocarbamoyl)phenyl]methyl]-3-chloro-4-fluorobenzenesulfonamide | 852918-02-6 | MFCD06683895 | 99.2% | C21H17ClFN3O4S | 10MG

Supplier: Medchemexpress LLC HY1345710MG
TCN 201 is a potent, selective, non-competitive antagonist of GluN1/GluN2A (NR2A-containing) NMDA receptors used as a research tool in neuroscience. It inhibits NR2A-containing receptors with a reported pIC50 ≈ 6.8 and shows markedly lower activity at NR2B-containing receptors. The compound is supplied at high purity and is intended for use in in vitro and in vivo experimental applications.
- Selective antagonist of NR2A-containing NMDA receptors.
- Potent activity (pIC50 ≈ 6.8 for NR2A).
- High chemical purity suitable for research (99.2%).
- Well characterized molecular properties (C21H17ClFN3O4S, MW 461.89).
- Useful for electrophysiology, pharmacology, and receptor subtype studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.